| Literature DB >> 26687117 |
Kirsten F L Douma1, Evelien Dekker2, Ellen M A Smets3, Cora M Aalfs4.
Abstract
This study aimed to gain insight into the gatekeeper role of surgeons and gastroenterologists (including residents) during a first consultation at a tertiary gastro-intestinal centre regarding referral for genetic counselling, and to test the feasibility of a checklist for indications for referral. Consecutive patients were invited before and after introduction of a checklist, to complete a questionnaire assessing their perception of discussing cancer genetic topics. Initial consultations were audiotaped to assess the quality of this discussion by gastroenterologists and surgeons. Data on completeness of the checklist and referral were collected from medical files. No significant differences were found between the Before and After group regarding patients' reports of discussing cancer in the family (77%, n = 34 vs 89%, n = 33, p = 0.16). In 28% (n = 10) of the audiotaped consultations family history was adequately discussed, in 58% (n = 21) it was considered inadequate and in 14% (n = 5) of consultations it was not discussed at all. A checklist was present in 53% (n = 27) of the medical files. Of these, 5 (19%) were incomplete. Gastroenterologists and surgeons (in training) have difficulty in fulfilling their gatekeeper role of recognizing patients at familial risk for CRC. Although they often discuss familial cancer during the initial consultation, their exploration seems insufficient to reveal indications for referral for genetic counselling. Therefore, healthcare professionals should not only understand genetics and the importance of cancer family history, but also be effective in the communication of this subject to enable more adequate referral of patients for genetic counselling.Entities:
Keywords: Gastroenterology; Genetic testing; Health communication; Hereditary colorectal neoplasms; Risk assessment
Mesh:
Year: 2016 PMID: 26687117 PMCID: PMC4803823 DOI: 10.1007/s10689-015-9861-5
Source DB: PubMed Journal: Fam Cancer ISSN: 1389-9600 Impact factor: 2.375
Translation of checklist
Coding scheme used in this study
| Traffic light | Category | Description of the content of the audiotaped consultation | Example | |
|---|---|---|---|---|
| Cancer in the family was | Cancer in the family? | |||
| Green | Adequately discussed | Yes | Discussed are: number of family members with cancer, type of cancer and age. A clear distinction was made between first and second-degree relatives | Do you have other family members with cancer? What type of cancer did they get? How old were they when they got cancer? |
| No | Family in the cancer is clearly discussed and there are no other cancers in this family | Do you have other family members with cancer? (and then ask probing questions, such as: Also, no second-degree family members?) | ||
| Orange | Inadequately discussed | Yes | The discussion does not fulfil the criteria mentioned above. e.g. the patient gives information about 1 person, and the specialist does not ask about the rest of the family | “How old is your mother?” (Instead of asking how old the family member was at the time of diagnosis) |
| No | The discussion is multi-interpretable, therefore it is unclear whether other family members have cancer | “Are there people in your family with cancer or polyps or that kind of thing?” | ||
| Red | Not discussed | n/a | The clinician does not ask about cancer in the family | n/a |
Characteristics of the population sample
| Variable | Before (n = 44) | After (n = 52) |
| ||
|---|---|---|---|---|---|
| Mean | Range | Mean | Range | ||
| Age in years | 67.9 | 43–91 | 62.6 | 39–86 | 0.02 |
* Because patients were invited by the researcher for permission to audiotape before the consultation, and by the nurse to complete the questionnaire after the consultation, some patients did not participate in both audiotaping and the questionnaire
Fig. 1Flow diagram of the inclusion
Discussion of cancer genetic topics
| Topics discussed according to the patients | Before (n = 44) | After (n = 36) | Χ2 ( |
| ||
|---|---|---|---|---|---|---|
| N | % | N | % | |||
| 1. Family members with cancer | 34 | 77 | 33 | 89 | 2.00 (1) | 0.16 |
| Patient has no family members with cancer | 12 | 27 | 11 | 30 | ||
| Patient has family members with cancer | 22 | 50 | 22 | 60 | ||
| 2. Who have had cancer | 20 | 95 | 21 | 100 | n/a | 1.00 |
| 3. First-degree family members | 19 | 95 | 21 | 96 | n/a | 1.00 |
| 4. Second-degree family members | 10 | 53 | 15 | 75 | 2.12 (1) | 0.15 |
| 5. Type of cancer of family members | 15 | 75 | 19 | 91 | n/a | 0.24 |
| 6. Age at which family members got cancer | 11 | 55 | 16 | 76 | 2.05 (1) | 0.15 |
| 7. Clinician took the initiative to discuss family history of cancer | 29 | 91 | 26 | 84 | n/a | 0.47 |
For question 2, 3, 5 and 7 the p value from the Fisher’s exact test (2-sided) is reported; the remaining p values are from the Pearson’s Chi square test
Topics discussed in case of possible hereditary cancer
| According to patients | Before | After | Χ2 ( |
| ||
|---|---|---|---|---|---|---|
| N | % | N | % | |||
| The consultation showed that the cancer is possibly hereditary | 5 | 24 | 7 | 33 | 0.47 (1) | 0.50 |
|
| ||||||
| Why the doctor thinks there is a possibility of hereditary cancer | 2 | 40 | 4 | 57 | ||
| Which types of genetic tests are available | 2 | 40 | 4 | 57 | ||
| How genetic testing works | 1 | 20 | 0 | 0 | ||
| The consequences of genetic testing for the patient self | 1 | 20 | 0 | 0 | ||
| The consequences of genetic testing for the patient’s family | 1 | 20 | 2 | 29 | ||
| Something else* | 0 | 0 | 2 | 29 | ||
| None of these topics were discussed with me | 2 | 40 | 1 | 14 | ||
* Advice given to sister, and explanation of statistically high risks